...
首页> 外文期刊>Journal of clinical laboratory analysis. >Detection of Human Epididymis Protein 4 (HE4) in Human Serum Samples Using a Specific Monoclonal Antibody‐Based Sandwich Enzyme‐Linked Immunosorbent Assay (ELISA)
【24h】

Detection of Human Epididymis Protein 4 (HE4) in Human Serum Samples Using a Specific Monoclonal Antibody‐Based Sandwich Enzyme‐Linked Immunosorbent Assay (ELISA)

机译:使用基于特异性单克隆抗体的三明治酶联免疫吸附法(ELISA)检测人血清样品中的人附睾蛋白4(HE4)

获取原文
   

获取外文期刊封面封底 >>

       

摘要

BackgroundThe human epididymis protein 4 (HE4) may have high specificity in the detection of malignant diseases, making the development of an immunoassay for HE4 essential. MethodsIn our study, a fusion gene was constructed encoded with the HE4 protein. This protein was then produced in the bacterial cells ( Escherichia coli ) and used to immunize mice in order to eventually generate hybridomas specific to HE4. The hybridoma supernatants were then screened, and four positive anti-HE4 cell lines were selected. These cell lines produce monoclonal antibodies against HE4 epitopes, as demonstrated in the Western blot as well as by direct enzyme-linked immunosorbent assay (ELISA). Using the developed antibodies, we successfully identified several good antibody pairs from the hybridomas, which allowed for the development of a sandwich ELISA to measure HE4 levels. By using the HE4 ELISA, we measured HE4 levels of 60 clinical human serum samples. ResultsCompared with the Food and Drug Administration (FDA) approved kit (Roche), our results showed a strong positive correlation to those of the FDA-approved kit. ConclusionsIn summary, highly sensitive antibody pairs were screened against HE4, and a sandwich ELISA was developed as an accurate analytical tool for the detection of HE4 in human serum, which could be especially valuable for diagnosing ovarian carcinomas.
机译:背景技术人附睾蛋白4(HE4)在检测恶性疾病方面可能具有很高的特异性,因此开发针对HE4的免疫测定必不可少。方法在我们的研究中,构建了一个由HE4蛋白编码的融合基因。然后,该蛋白质在细菌细胞(大肠杆菌)中产生,并用于免疫小鼠,以最终产生特异于HE4的杂交瘤。然后筛选杂交瘤上清液,并选择四种阳性抗HE4细胞系。这些细胞系产生针对HE4表位的单克隆抗体,如Western印迹法以及直接酶联免疫吸附测定(ELISA)所证明的。使用已开发的抗体,我们成功地从杂交瘤中鉴定出数个良好的抗体对,从而开发了夹心ELISA来测量HE4水平。通过使用HE4 ELISA,我们测量了60种临床人血清样品的HE4水平。结果与美国食品药品监督管理局(FDA)批准的试剂盒(Roche)相比,我们的结果显示与FDA批准的试剂盒具有很强的正相关性。结论总而言之,针对HE4筛选了高敏感性抗体对,并开发了夹心ELISA作为检测人血清中HE4的准确分析工具,这对于诊断卵巢癌特别有价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号